Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1656PDF: 1004HTML: 1036figures: 246table 1: 256table2: 252table3: 259 -
THE ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
308PDF: 266HTML: 135 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
954PDF: 537HTML: 1333 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3991PDF: 1741HTML: 897Figures . Eliassian: 343 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1103PDF: 621HTML: 2240Cover Letter: 270 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1134PDF: 588HTML: 761 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4760Suppl. Files: 1296PDF: 1195Html: 349 -
IMMUNOLOGY OF TUBERCULOSIS
6015PDF: 2387HTML: 7385Untitled: 254 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2834PDF: 1285HTML: 297 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1615PDF: 1436HTML: 126 -
-
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3281PDF: 1112HTML: 3255 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1317PDF: 905HTML: 2210Figue 1: 217 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3933PDF: 1388HTML: 3982Untitled: 301Untitled: 326 -
-
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1929PDF: 642HTML: 17009Figure 4: 239Figure 3: 205Figure 2: 202Figure 1: 231 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3668PDF: 1504HTML: 2756 -
COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia
1087PDF: 784HTML: 171 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5054PDF: 1934HTML: 2908Untitled: 349 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3760PDF: 1440HTML: 6379 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1385PDF: 1026HTML: 359 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1726PDF: 1119HTML: 156 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3631PDF: 1371HTML: 8441 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1862PDF: 887HTML: 937jdoe, table 2 infections CML .doc: 263jdoe, table 1 infections CML .doc: 238 -
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS: LOW INCIDENCE OF PRIMARY NEOPLASM AS A TRIGGER IN A CASE SERIES FROM TURKEY
1748PDF: 1031HTML: 276Figure 1: 227







